Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | FBP1 | P09467 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.36 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.36 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.36 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1373854 | 1.00 | GRIK1 (0.44) | GRIK1CYP2C9TRPA1FBP1ALDH1A1 | |
| SCHEMBL10955277 | 0.96 | GRIK1 (0.44) | GRIK1CYP2C9TRPA1FBP1ALDH1A1 | |
| SCHEMBL7178914 | 0.94 | GRIK1 (0.41) | GRIK1CYP2C9TRPA1FBP1ALDH1A1 | |
| SCHEMBL20506870 | 0.88 | PDE4A (0.43) | GRIK1CYP2C9TRPA1FBP1ALDH1A1 | |
| SCHEMBL5069345 | 0.88 | PDE4A (0.43) | GRIK1CYP2C9TRPA1FBP1ALDH1A1 | |
| SCHEMBL23069335 | 0.80 | ALDH1A1 (0.40) | CYP2C9FBP1ALDH1A1AKR1C3AKR1C1 | |
| SCHEMBL4160807 | 0.80 | ALDH1A1 (0.40) | CYP2C9FBP1ALDH1A1AKR1C3AKR1C1 | |
| SCHEMBL23444 | 0.80 | ALDH1A1 (0.40) | CYP2C9FBP1ALDH1A1AKR1C3AKR1C1 | |
| SCHEMBL4168927 | 0.80 | ALDH1A1 (0.40) | CYP2C9FBP1ALDH1A1AKR1C3AKR1C1 | |
| SCHEMBL6200543 | 0.80 | KDM4E (0.46) | CYP2C9ALDH1A1HTTPTGS2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3498713-B1 | TRANSPARENT NUCLEATING AGENT COMPOSITION COMPRISING SORBITOL TRIACETALS AND MONOACETALS | GCH TECH CO LTD (CN) | 2022-01-05 | — | — | EP | disclosed |
| EP-3498713-A1 | TRANSPARENT NUCLEATING AGENT COMPOSITION COMPRISING SORBITOL TRIACETALS AND MONOACETALS | GCH Technology Co., Ltd. (CN) | 2019-06-19 | — | — | EP | disclosed |
| US-10208057-B2 | Nucleator composition comprising sorbitol acetal, sorbitol diacetal and sorbitol triacetal | GCH TECHNOLOGY CO., LTD. (CN) | 2019-02-19 | — | — | US | disclosed |
| US-20180273545-A1 | NUCLEATOR COMPOSITION COMPRISING SORBITOL ACETAL, SORBITOL DIACETAL AND SORBITOL TRIACETAL | GCH TECHNOLOGY CO., LTD. (CN) | 2018-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180273545-A1 | NUCLEATOR COMPOSITION COMPRISING SORBITOL ACETAL, SORBITOL DIACETAL AND SORBITOL TRIACETAL | SORD, DERA, SMCHD1 | GRIK1 4246/4885CYP2C9 4361/4885TRPA1 2676/4885 |
| US-10208057-B2 | Nucleator composition comprising sorbitol acetal, sorbitol diacetal and sorbitol triacetal | SORD, DERA, SMCHD1 | GRIK1 4155/4885CYP2C9 4326/4885TRPA1 2243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.